Area of research
Pharmacology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Neonatal Health and Biochemistry, Drug Transport and Resistance Mechanisms, and Metabolism and Genetic Disorders.
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice.
Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease
Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα
Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans
Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia
Triclosan: A Widespread Environmental Toxicant with Many Biological Effects
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes
The NIEHS Superfund Research Program: 25 Years of Translational Research for Public Health
The commonly used antimicrobial additive triclosan is a liver tumor promoter
Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)
Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice
Triclocarban Mediates Induction of Xenobiotic Metabolism through Activation of the Constitutive Androstane Receptor and the Estrogen Receptor Alpha
Targeting the pregnane X receptor in liver injury